Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain

Type 2 DNA topoisomerases (Top2) are critical components of key protein complexes involved in DNA replication, chromosome condensation and segregation, as well as gene transcription. The Top2 were found to be the main targets of anticancer agents, leading to intensive efforts to understand their functional and physiological role as well as their molecular structure. Post-translational modifications have been reported to influence Top2 enzyme activities in particular those of the mammalian Top2α isoform. In this study, we identified phosphorylation, and for the first time, acetylation sites in the human Top2α isoform produced in eukaryotic expression systems. Structural analysis revealed that acetylation sites are clustered on the catalytic domains of the homodimer while phosphorylation sites are located in the C-terminal domain responsible for nuclear localization. Biochemical analysis of the eukaryotic-specific K168 residue in the ATPase domain shows that acetylation affects a key position regulating ATP hydrolysis through the modulation of dimerization. Our findings suggest that acetylation of specific sites involved in the allosteric regulation of human Top2 may provide a mechanism for modulation of its catalytic activity.Facultad de Ciencias ExactasInstituto de Física de Líquidos y Sistemas Biológico

Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain

Type 2 DNA topoisomerases (Top2) are critical components of key protein complexes involved in DNA replication, chromosome condensation and segregation, as well as gene transcription. The Top2 were found to be the main targets of anticancer agents, leading to intensive efforts to understand their functional and physiological role as well as their molecular structure. Post-translational modifications have been reported to influence Top2 enzyme activities in particular those of the mammalian Top2α isoform. In this study, we identified phosphorylation, and for the first time, acetylation sites in the human Top2α isoform produced in eukaryotic expression systems. Structural analysis revealed that acetylation sites are clustered on the catalytic domains of the homodimer while phosphorylation sites are located in the C-terminal domain responsible for nuclear localization. Biochemical analysis of the eukaryotic-specific K168 residue in the ATPase domain shows that acetylation affects a key position regulating ATP hydrolysis through the modulation of dimerization. Our findings suggest that acetylation of specific sites involved in the allosteric regulation of human Top2 may provide a mechanism for modulation of its catalytic activity.Fil: Bedez, Claire. Université de Strasbourg; FranciaFil: Lotz, Christophe. Université de Strasbourg; FranciaFil: Batisse, Claire. Université de Strasbourg; FranciaFil: Broeck, Arnaud Vanden. Université de Strasbourg; FranciaFil: Stote, Roland H.. Université de Strasbourg; FranciaFil: Howard, Eduardo Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Física de Líquidos y Sistemas Biológicos. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Física de Líquidos y Sistemas Biológicos; ArgentinaFil: Pradeau-Aubreton, Karine. Université de Strasbourg; FranciaFil: Ruff, Marc. Université de Strasbourg; FranciaFil: Lamour, Valérie. Université de Strasbourg; Franci

Production of unstable proteins through the formation of stable core complexes

International audiencePurification of proteins that participate in large transient complexes is impeded by low amounts, heterogeneity, instability and poor solubility. To circumvent these difficulties we set up a methodology that enables the production of stable complexes for structural and functional studies. This procedure is benchmarked and applied to two challenging protein families: the human steroid nuclear receptors (SNR) and the HIV-1 pre-integration complex. In the context of transcriptional regulation studies, we produce and characterize the ligand-binding domains of the glucocorticoid nuclear receptor and the oestrogen receptor beta in complex with a TIF2 (transcriptional intermediary factor 2) domain containing the three SNR-binding motifs. In the context of retroviral integration, we demonstrate the stabilization of the HIV-1 integrase by formation of complexes with partner proteins and DNA. This procedure provides a powerful research tool for structural and functional studies of proteins participating in non-covalent macromolecular complexes

The HIV-1 Pre-Integration Complexes: Structures, Functions and Dynamics

International audienc

Unstable Protein Purification Through the Formation of Stable Complexes

International audienc

Efficient production of protein complexes in mammalian cells using a poxvirus vector

Abstract Background: The production of full length, biologically active proteins in mammalian cells is critical for a wide variety of purposes ranging from structural studies to preparation of subunit vaccines. Prior research has shown that Modified vaccinia virus Ankara encoding the bacteriophage T7 RNA polymerase (MVA-T7) is particularly suitable for high level expression of proteins upon infection of mammalian cells. The expression system is safe for users and 10-50 mg of full length, biologically active proteins may be obtained in their native state, from a few litres of infected cell cultures. Results: Here we report further improvements which allow an increase in the ease and speed of recombinant virus isolation, the scale-up of protein production and the simultaneous synthesis of several polypeptides belonging to a protein complex using a single virus vector. Isolation of MVA-T7 viruses encoding foreign proteins was simplified by combining positive selection for virus recombinants and negative selection against parental virus, a process which eliminated the need for tedious plaque purification. Scale-up of protein production was achieved by infecting a BHK 21 suspension cell line and inducing protein expression with previously infected cells instead of virus, thus saving time and effort in handling virus stocks. Protein complexes were produced from infected cells by concatenating the Tobacco Etch Virus (TEV) N1A protease sequence with each of the genes of the complex into a single ORF, each gene being separated from the other by twin TEV protease cleavage sites. We report the application of these methods to the production of a complex formed on the one hand between the HIV-1 integrase and its cell partner LEDGF and on the other between the HIV-1 VIF protein and its cell partners APOBEC3G, CBFβ, Elo B and Elo C. Conclusions: The strategies developed in this study should be valuable for the overexpression and subsequent purification of numerous protein complexes

Structural and functional studies of the HIV-1 pre-integration complex

International audienc

Expression of the IN/LEDGF complex.

A. Schematic drawing of the ORFs inserted into the MVA-T7 virus behind a T7 promoter and encoding a polyprotein including from 5’ to 3’ the TEV protease, LEDGF, two distinct copies of the HIV-1 IN and YFP. Each ORF is separated from the other by twin TEV cleavage sites (perpendicular arrows). B. Purification of the IN-LEDGF complex from 12 109 suspension BHK 21 cells infected with an MVA recombinant encoding the complex. The His-tagged complex was first purified by HPLC on a HisTrap excel Ni sepharose column (not shown) then the pooled fractions were concentrated and separated by size fractionation on a Hi Load 16/60 Superdex-200 column. The position of the B6 peak fraction is boxed in red. C. PAGE was performed on aliquots of the fractions recovered from the Superdex-200 column. Arrows point to the LEDGF and IN proteins stained with Coomassie blue. D. 3’ processing test of the IN/LEDGF complex. The release of GT-fluorescent dinucleotide was monitored by following fluorescence anisotropy as a function of time for the IN-LEDGF complex in the absence of DNA; in the presence of non-specific DNA or in the presence of HIV-1 U5 DNA.</p

Selection and amplification of MVA-T7 recombinants.

(TIF)</p

Expression of β glucuronidase in adherent BHK21 cells or suspension BHK21 C13-2P cells.

(DOCX)</p